Molecular diagnosis and detection of Pneumocystis jirovecii DHPS and DHFR genotypes in respiratory specimens from Colombian patients

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 3, 2012, Pages 204-213

  Muñoz, Cesar ^a   Zuluaga, Alejandra ^a   Restrepo, Angela ^a   Tobón, Angela ^a,b   Cano, Luz Elena ^a,c   Gonzalez, Angel ^a,c  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b E S E Hospital La María   (Colombia)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

DHFR; DHPS; MtLSUrRNA; PcP; Pneumocystis jirovecii

Indexed keywords

FUNGAL DNA; LARGE SUBUNIT RIBOSOMAL RNA; MITOCHONDRIAL RNA;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CODON; COLOMBIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIHYDROFOLATE REDUCTASE GENE; DIHYDROPTEROATE SYNTHASE GENE; ETHNIC GROUP; FEMALE; FUNGAL GENE; FUNGUS IDENTIFICATION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; SENSITIVITY AND SPECIFICITY; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLOMBIA; DIHYDROPTEROATE SYNTHASE; DNA, FUNGAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; RNA; SENSITIVITY AND SPECIFICITY; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

EID: 84856603942     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.11.015     Document Type: Article

References (59)

1. Armbruster C., Hassl A., Kriwanek S. Pneumocystis carinii colonisation in the absence of immunosuppression. Scand. J. Infect. Dis. 1997, 29:591-593.
2. Azoulay E., Bergeron A., Chevret S., Bele N., Schlemmer B., Menotti J. Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009, 135:655-661.
3. Bialek R., Feucht A., Aepinus C., Just-Nübling G., Robertson V.J., Knobloch J., Hohle R. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J. Clin. Microbiol. 2002, 40:1644-1647.
4. Bozzette S.A., Finkelstein D.M., Spector S.A., Frame P., Powderly W.G., He W., Phillips L., Craven D., Van der Horst C., Feinberg J. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N. Engl. J. Med. 1995, 332:693-699.
5. Caliendo A.M., Hewitt P.L., Allega J.M., Keen A., Ruoff K.L., Ferraro M.J. Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens. J. Clin. Microbiol. 1998, 36:979-982.
6. Cartwright C.P., Nelson N.A., Gill V.J. Development and evaluation of a rapid and simple procedure for detection of Pneumocystis carinii by PCR. J. Clin. Microbiol. 1994, 32:1634-1638.
7. Dini L., Du Plessis M., Frean J., Fernandez V. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J. Clin. Microbiol. 2010, 48:2016-2021.
8. Djamin R.S., Drent M., Schreurs A.J., Groen E.A., Wagenaar S.S. Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients. Bronchoalveolar lavage vs. bronchial brushing. Acta Cytol. 1998, 42:933-938.
9. Dujardin B., Vand der Ende J., Van Gompel A., Unger P., Van der Stuyft P. Likelihood ratios: a real improvement for clinical decision making?. Eur. J. Epidemiol. 1994, 10:29-36.
10. Esteves F., Gaspar J., Marques T., Leite R., Antunes F., Mansinho K., Matos O. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin. Microbiol. Infect. 2010, 16:878-884.
11. Esteves F., Gaspar J., De Sousa B., Antunes F., Mansinho K., Matos O. Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii pneumonia: development of a multiplex PCR-single-base-extension methodology. J. Clin. Microbiol. 2011, 49:1810-1815.
12. Estrada S., González M.A., Giraldo A.M., Bedoya F., Jaramillo E., Posada P., Montoya C.M. Etiología de la neuropatía en pacientes con SIDA. Act. Med. Colomb. 1993, 18:164-171.
13. Flori P., Bellete B., Durand F., Raberin H., Cazorla C., Hafid J., Lucht F., Sunt R.T. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J. Med. Microbiol. 2004, 53:603-607.
14. Galen R.S., Gambino S.R. Beyond normality. The predictive value and efficiency of medical diagnosis 1975, 115-116. John Wiley & Sons, Inc., New York. R.S. Galen, S.R. Gambino (Eds.).
15. Gupta R., Mirdha B.R., Guleria R., Kumar L., Samantaray J.C., Agarwal S.K., Kumar S., Luthra K. Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens. Diagn. Microbiol. Infect. Dis. 2009, 64:381-388.
16. Hardy W.D., Feinberg J., Finkelstein D.M., Power M.E., He W., Kaczka C., Frame P.T., Holmes M., Waskin H., Fass R.J., Powderly W.G., Steigbigel R.T., Zuger A., Holzman R.S. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N. Engl. J. Med. 1992, 327:1842-1848.
17. Helweg-Larsen J. Pneumocystis jirovecii applied molecular microbiology, epidemiology and diagnosis. Dan. Med. Bull. 2002, 51:251-273.
18. Helweg-Larsen J., Benfield T.L., Eugen-Olsen J., Lundgren J.D., Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347-1351.
19. Huang L., Beard C.B., Creasman J., Levy D., Duchin J.S., Lee S., Pieniazek N., Carter J.L., del Rio C., Rimiand D., Navin T.R. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 2000, 182:1192-1198.
20. Iliades P., Meshnick S.R., Macreadie I.G. Dihydropteroate synthase mutations in Pneumocystis jirovecii can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model. Antimicrob. Agents Chemother. 2004, 48:2617-2623.
21. Iliades P., Walker D.J., Castelli L., Satchell J., Meshnick S.R., Macreadie I.G. Cloning of the Pneumocystis jirovecii trifunctional FAS gene and complementation of its DHPS activity in Escherichia coli. Fung. Genet. Biol. 2004, 41:1053-1062.
22. Iliades P., Meshnick S.R., Macreadie I.G. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. Antimicrob. Agents Chemother. 2005, 49:741-748.
23. Jensen L., Jensen A.V., Praygod G., Kidola J., Faurholt-Jepsen D., Changalucha J., Range N., Friis H., Helweg-Larsen J., Jensen J.S., Andersen A.B. Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania. BMC Infect. Dis. 2010, 10:140-147.
24. Kazanjian P., Locke A.B., Hossler P.A., Lane B.R., Bartlett M.S., Smith J.W., Cannon M., Meshnick S.R. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998, 12:873-878.
25. Kazanjian P., Armstrong W., Hossler P.A., Burman W., Richardson J., Lee C.H., Crane L., Katz J., Meshnick S.R. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 2000, 182:551-557.
26. Klein N.C., Duncanson F.P., Lenox T.H., Forszpaniak C., Sherer C.B., Quentzel H., Nunez M., Suarez M., Kawwaff O., Pitta-Alvarez A., Freeman K., Wormser G.P. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. AIDS 1992, 6:301-305.
27. Lane B.R., Ast J.C., Hossler P.A., Mindell D.P., Bartlett M.S., Smith J.W., Meshinick S.R. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J. Infect. Dis. 1997, 175:482-485.
28. Leigh T.R., Kangro H.O., Gazzard B.G., Jefferies D.J., Collins J.V. DNA amplification by polymerase chain reaction to detect subclinical Pneumocystis carinii colonization in HIV-positive and HIV-negative homosexuals with and without respiratory symptoms. Respir. Med. 1993, 87:525-529.
29. Ma L., Borio L., Masur H., Kovacs J. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 1999, 180:1969-1978.
30. Ma L., Kovacs J.A., Cargnel A., Valerio A., Fantoni G., Atzori C. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J. Infect. Dis. 2002, 185:1530-1532.
31. Meneau I., Sanglard D., Bille J., Hauser P.M. Pneumocystis jirovecii dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in saccharomyces cerevisiae. Antimicrob. Agents Chemother. 2004, 48:2610-2616.
32. Moukhlis R., Boyer J., Lacube P., Bolognini J., Roux P., Hennequin C. Linking Pneumocystis jirovecii sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae. Clin. Microbiol. Infect. 2010, 16:501-507.
33. Nahimana A., Rabodonirina M., Zanetti G., Meneau I., Francioli P., Bille J., Hauser P.M. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J. Infect. Dis. 2003, 188:1017-1023.
34. Nahimana A., Rabodonirina M., Bille J., Francioli P., Hauser P.M. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob. Agents Chemother. 2004, 48:4301-4305.
35. Nevez G., Raccurt C., Jounieaux V., Dei-Cas E., Mazars E. Pneumocystosis versus pulmonary Pneumocystis carinii colonisation in HIV-negative and HIV-positive patients. AIDS 1999, 13:535-536.
36. Olsson M., Elvin K., Lofdahl S., Linder E. Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J. Clin. Microbiol. 1993, 31:221-226.
37. Olsson M., Stralin K., Holmberg H. Clinical significance of nested polymerase chain reaction and immunofluorescence for detection of Pneumocystis carinii pneumonia. Clin. Microbiol. Infect. 2001, 7:492-497.
38. Pinlaor S., Mootsikapun P., Pinlaor P., Phunmanee A., Pipitgool V., Sithithaworn P., Chumpia W., Sithithaworn J. PCR diagnosis of Pneumocystis carinii on sputum and bronchoalveolar lavage samples in immuno-compromised patients. Parasitol. Res. 2004, 94:213-218.
39. Robberts F.J., Chalkley L.J., Weyer K., Goussard P., Liebowitz L.D. Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa. J. Clin. Microbiol. 2005, 43:1443-1444.
40. Robberts F., Liebowitz L.D., Chalkley L.J. Polymerase chain reaction detection of Pneumocystis jirovecii: evaluation of 9 assays. Diagn. Microbiol. Infect. Dis. 2007, 58:385-392.
41. Ruffini D.D., Madhi S.A. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 2002, 1516:105-112.
42. Russian D.A., Levine S.J. Pneumocystis carinii pneumonia in patients without HIV infection. Am. J. Med. Sci. 2001, 321:56-65.
43. Saah A.J., Hoover D.R., Peng Y., Phair J.P., Visscher B., Kingsley L.A., Schrager L.K. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. JAMA 1995, 273:1197-1202.
44. Saksirisampant W., Eampokalap B., Chantharodevong R., Changthong R. Comparison of methods for identification of Pneumocystis carinii in bronchoalveolar lavage fluid. J. Med. Assoc. Thai. 2002, 85(Suppl 1):S407-S414.
45. Shen L.X., Basilion J.P., Stanton V.P. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc. Natl. Acad. Sci. U S A. 1999, 96:7871-7876.
46. Siripattanapipong S., Leelayoova S., Mungthin M., Worapong J., Tan-Ariya P. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. Med. Mycol. 2009, 46:389-392.
47. Takahashi T., Hosoya N., Endo T., Nakamura T., Sakashita H., Kimura K., Ohnishi K., Nakamura Y., Iwamoto A. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J. Clin. Microbiol. 2000, 38:3161-3164.
48. Takahashi T., Endo T., Nakamura T., Sakashita H., Kimura K., Ohnishi K., Kitamura Y., Iwamoto A. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J. Med. Microbiol. 2002, 51:510-515.
49. Tiley S.M., Marriott D.J., Harkness J.L. An evaluation of four methods for the detection of Pneumocystis carinii in clinical specimens. Pathology 1994, 26:325-328.
50. Totet A., Latouche S., Lacube P., Pautard J.C., Jounieaux V., Raccurt C., Roux P., Nevez G. Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg. Infect. Dis. 2004, 10:667-673.
51. Turner D., Schwarz Y., Yust I. Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues. Eur. Respir. J. 2003, 21:204-208.
52. Valerio A., Tronconi E., Mazza F., Fantoni G., Atzori C., Tartarone F., Duca P., Cargnel A. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J. Acquir. Immune. Defic. Syndr. 2007, 45:521-528.
53. Velásquez G., Betancur J., Estrada S., Naglés J., Orozco B., Ospina S., Panneso R., Restrepo A., Robledo J. Infecciones observadas en 193 pacientes con SIDA: Estudio multicéntrico en la ciudad de Medellín 1987-1992. Act. Med. Colomb. 1993, 18:56-65.
54. Vélez L.A., Correa L.T., Maya M.A., Mejía P., Bedoya V.I., Ortega J., Ortega H. Utilidad del manejo protocolario de las muestras de Lavado Broncoalveolar (LBA), en el estudio diagnóstico de neumopatías en pacientes inmunocomprometidos. Infectio 2002, 6:118-125.
55. Visconti E., Ortona E., Mencarini P., Margutti P., Marinaci S., Zolfo M., Siracusano A., Tamburrini E. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int. J. Antimicrob. Agents. 2001, 18:547-551.
56. Volpe F., Ballantine S.P., Delves C.J. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hydroxymethyldihydropterin pyrophosphokinase and dihydropteroate synthase. Eur. J. Biochem. 1993, 216:449-458.
57. Wakefield A.E., Pixley F.J., Banerji S., Sinclair K., Miller R.F., Moxon E.R., Hopkin J.M. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carnii DNA of rat and human origin. Mol. Biochem. Parasitol. 2002, 43:69-76.
58. White T.J., Bruns T., Lee S., Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications 1990, 315-322. Academic Press Inc., San Diego, CA. M.A. Innis, D.H. Gelfand, J.J. Sninsky, W. T.J. (Eds.).
59. Wilson J.W., Limper A.H., Grys T.E., Karre T., Wengenack N.L., Binnicker M.J. Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. Diagn. Microbiol. Infect. Dis. 2011, 69:145-152.